Access 2.8M+ Filings Sign Up Free
Addex Therapeutics Ltd Logo

Addex Therapeutics Ltd | ADXN - Profile, Filings, Stock Info & Investor Relations Data

Addex Therapeutics Ltd | ADXN
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Pharmaceuticals
Country
Switzerland
Founded
2002
Addex Therapeutics Ltd (ADXN)

Company Profile

Website
Investor Relations

About Addex Therapeutics Ltd

Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for neurological disorders.

Allosteric modulators offer several potential advantages over conventional non-allosteric molecules and may offer an improved therapeutic approach to conventional "orthosteric" small molecule or biological drugs. Addex's allosteric modulator drug discovery platform targets receptors and other proteins that are recognized as essential for therapeutic intervention.

Addex's lead drug candidate, dipraglurant (mGlu5 negative allosteric modulator or NAM), is in a pivotal registration clinical trial for Parkinson’s disease levodopa induced dyskinesia (PD-LID).

Employees

28

Market Presence

Worldwide

Headquarters

c/o Addex Pharma SA, Chemin des Aulx 12
1228, Plan-Les-Ouates
Switzerland

Addex Therapeutics Ltd (ADXN)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

Create Free Account Sign In

Addex Therapeutics Ltd (ADXN)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

↑
N/A (Executive member)
Buy CHF 301,345.00 CHF 0.04 27.11.23
↑
N/A (Executive member)
Buy CHF 53,760.00 CHF 0.04 27.11.23
↑
N/A (Executive member)
Buy CHF 45,450.00 CHF 0.04 27.11.23
↑
N/A (Non-Executive member)
Buy CHF 44,856.00 CHF 0.04 27.11.23
↑
N/A (Non-Executive member)
Buy CHF 24,423.00 CHF 0.04 27.11.23
↑
N/A (Executive member)
Buy CHF 5,487.00 CHF 0.04 27.11.23
↑
N/A (Non-Executive member)
Buy CHF 3,927.00 CHF 0.04 27.11.23
↑
N/A (Executive member)
Buy CHF 2,150.00 CHF 0.04 27.11.23

Addex Therapeutics Ltd (ADXN)
Stock & Investor Information

ISINs

CH0029850754
CH0414782943
US00654J2069

LEI

89450068Y9KVP2MQGH86

Stock Exchange Listings

SIX Swiss Exchange

Industry Classification

Sector
Health Care
Industry
Pharmaceuticals